Abstract: Methods of treating and preventing hepatotoxicity through inhibiting interleukin 11 (IL-11)-mediated signalling are disclosed, as well as agents for use in such methods.

Abstract: An expander for widening and holding apart an opening of a tissue. The expander may include a body configured to deform from a compacted state into a pre-determined shape in an expanded state in response to a pre-determined physiological condition the body is exposed to. The body with the pre-determined shape in the expanded state may be configured to hold apart the opening of the tissue.

Abstract: IL-11Ra antibodies are disclosed. Also disclosed are compositions comprising the IL-11Ra antibodies, and methods using the IL-11Ra antibodies.

Abstract: A method of modifying a retina fundus image for a deep learning model is disclosed. In a described embodiment, the method includes converting a retina fundus image to a binary image by converting pixels of the retina fundus image to low intensity modified pixels and high intensity modified pixels of the binary image, and determining a first boundary between the low intensity modified pixels and high intensity modified pixels of the binary image. The method further includes removing outlier boundary values from the first boundary, constructing a second boundary from remaining boundary values, identifying the pixels of the retina fundus image that are within the second boundary, and constructing a modified retina fundus image containing the identified pixels for a deep learning model.

Abstract: IL-11 antibodies are disclosed. Also disclosed are compositions comprising the IL-11 antibodies, and methods using the IL-11 antibodies.

Abstract: The invention relates to the expansion of T cells and particularly, although not exclusively, to the expansion of gamma delta T cells, and the optimization of medium, serum and cytokine combinations for large-scale ex vivo expansion of gamma delta T cells for clinical use.

Abstract: A medical image processing method of determining a fractional flow reserve through a stenosis of a coronary artery from medical image data is disclosed. The medical image data comprises a set of images of a coronary region of a patient. The coronary region includes the stenosis. The method comprises: reconstructing a three dimensional model of a coronary artery tree of the patient from the medical image data; determining stenosis dimensions from the three dimensional model of the coronary artery tree of the patient; simulating blood flow in the three dimensional model of the coronary artery tree of the patient to determine modeled flow rates; using an analytical model depending on the stenosis dimensions to predict a modeled pressure drop over the stenosis from the modeled flow rates; and determining the fractional flow reserve through the stenosis from the modeled pressure drop.

Abstract: This invention relates to a system and a method for continuous monitoring of the heart activities via a mobile device and algorithm to detect heart anomalies based on readings on electrocardiogram (ECG) and phonocardiogram (PCG).

Abstract: Provided is a glaucoma valve, a casing for containing a glaucoma valve and a glaucoma drainage device including the glaucoma valve and/or the casing. The valve includes a flow channel having an inlet and an outlet and a valve member connected to the outlet of the flow channel. The valve member may be formed from a degradable polymer or a combination of degradable polymer and non-degradable polymer. The valve may have a first flow channel, the interior of which may be coated with a degradable polymer, such that in use, the polymer degrades to allow a greater flow of fluid through the flow channel. The valve may include a second flow channel, which may be arranged in parallel to the first flow channel. The casing may be formed from a degradable polymer, such as a biodegradable polymer.

Abstract: Methods of treating a dengue virus (DENV) infection in a human subject, comprising administering to the human subject a compound of Formula (I), or pharmaceutical composition comprising a compound of Formula (I): A compound of Formula (I) can be administered within onset of fever to 72 hours of fever onset due to dengue infection and then every 6 to 12 hours until there is an improvement in the infection or between from about 1 day to about 10 days. The methods of the invention can be used to treat primary and secondary DENV 1-4 viral infections.

Abstract: According to embodiments of the present invention, an embolic device for embolizing a target vascular site is provided. The embolic device includes a biodegradable shape memory element having an original shape and a deformed shape, wherein the biodegradable shape memory element in the deformed shape is in at least one dimension of a smaller size than the biodegradable shape memory element in the original shape, and wherein the biodegradable shape memory element is provided in the deformed shape and configured to resume the original shape in response to an external stimulus being applied to the biodegradable shape memory element in its deformed shape, to embolize the target vascular site and prevent fluid flow through the target vascular site. According to further embodiments of the present invention, an apparatus for embolizing a target vascular site and a method thereof are also provided.

Abstract: According to embodiments of the present invention, a sensor patch for detecting extravasation is provided. The sensor patch includes an elastic film, and at least one sensing electrode disposed on the elastic film, wherein an electrical resistance of the at least one sensing electrode is changeable in response to a force acting on the at least one sensing electrode. According to further embodiments of the present invention, a sensing device is also provided.

Abstract: The present disclosure relates to an illumination device for illuminating a body cavity in a surgical space during a surgical procedure.

Abstract: The present invention relates to substituted azole derivatives in combination with cytokines in the ex vivo expansion of CD34+ hematopoietic stem and progenitor cells (HSPC) in a biological sample, more particularly the expansion of these cells obtained from non-enriched, i.e., the mononuclear fraction of the biological sample. The present invention further describes the transplantation regimen of the expanded hematopoietic graft developed through xenotransplantation studies. In a preferred embodiment, the combination comprising the azole based compounds and cytokines selected from SCF, TPO, FLT-3L and IGFBP-2 and results in the expansion of expansion of CD45+CD34+CD38?CD45RA?CD90+ hematopoietic stem cells and/or CD45+CD34+CD38?CD45RA?CD90+CD49f+ hematopoietic stem cells and/or CD45+CD34+CD38?CD45RA? hematopoietic progenitor cells from the mononucleated cells isolated from umbilical cord blood.

Abstract: We describe a method of monitoring the state of a cell, tissue, organ or organism. The method comprises establishing, for a sample of micro-particles from the cell, tissue, organ or organism, a ratio. The ratio is of a selected polypeptide in microparticles which comprise GM1 gangliosides, preferably which bind to Cholera Toxin B (CTB) (“GM1 ganglioside microparticle polypeptide”) to the selected polypeptide in microparticles which comprise exposed phos—photidylserine, preferably which bind to Annexin V (“Annexin V microparticle polypeptide”). The GM1 ganglioside microparticle polypeptide to Annexin V microparticle polypeptide ratio so established may be indicative of the state of the cell, tissue, organ or organism.

Abstract: An IL-11 binding receptor capable of binding to IL-11 and inhibiting IL-11 mediated signalling is disclosed. Also disclosed are compositions comprising the IL-11 binding receptor and methods using the IL-11 binding receptor.

Abstract: There is provided a monolithically integrated multimodal sensor device for intracranial neuromonitoring, the sensor device including: a single substrate; a temperature sensor formed on a first portion of the single substrate for detecting temperature; a pressure sensor formed on a second portion of the single substrate for detecting intracranial pressure; and an oxygen sensor formed on a third portion of the single substrate for detecting oxygen concentration. In particular, sensing portions of the temperature sensor, the oxygen sensor and the pressure sensor, respectively, are formed at different layers of the sensor device. There is also provided an integrated multimodal sensor system incorporating the sensor device and the associated methods of fabrication.

Abstract: The invention relates to a multilayered nanoparticle for delivery of RNA to a cell and methods of manufacturing and using the same. The multilayered nanoparticle has a core nanoparticle coated by alternating positively and negatively charged polymer layers, wherein the at least one of the negatively charged polymer layers is RNA.

Abstract: Natural-KilleifT-Cell Lymphoma (NKTCL) susceptibility prediction, diagnosis and therapy. The invention relates to a method for predicting Natural Killer T-cell Lymphoma (NKTCL) susceptibility and/or diagnosing NKTCL in a subject comprising testing for JAK mutations. The invention also relates to a method of screening for candidate agents capable of treating NKTCL using a cell line comprising at least one JAK mutation. The invention includes an NKTCL animal model comprising at least one JAK mutation. The invention also includes JAK inhibitors for treating NKTCL.

Abstract: Diagnosis, treatment and prophylaxis of diseases and conditions associated with smooth muscle cell (SMC) dysfunction are provided through the inhibition of IL-11-mediated signalling.